The effects of food and divided dosing on the bioavailability of oral vinorelbine

[1]  D. Lacombe,et al.  Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  H. Pinedo,et al.  Vinorelbine: a horse of a different color? , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Y. Tam.  Individual Variation in First-Pass Metabolism , 1993, Clinical pharmacokinetics.

[4]  J. Hainsworth,et al.  Bioavailability of low-dose oral etoposide. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Budman.  New vinca alkaloids and related compounds. , 1992, Seminars in oncology.

[6]  J. Sørensen.  Vinorelbine. A review of its antitumour activity in lung cancer. , 1992, Drugs.

[7]  R. Donehower,et al.  The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. , 1991, Pharmacology & therapeutics.

[8]  W. Koo,et al.  Interactions Between Hydralazine and Oral Nutrients in Humans , 1991, Therapeutic drug monitoring.

[9]  Vincent Meininger,et al.  Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules , 1990, International journal of cancer.

[10]  V. Meininger,et al.  In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence. , 1989, Seminars in oncology.

[11]  P. Potier.  The synthesis of Navelbine prototype of a new series of vinblastine derivatives. , 1989, Seminars in oncology.

[12]  Stewart Ja,et al.  Navelbine: a new step in cancer therapy? , 1989 .

[13]  V. Meininger,et al.  Biochemical effects of Navelbine on tubulin and associated proteins. , 1989, Seminars in oncology.

[14]  J. Armand,et al.  Navelbine: a new step in cancer therapy? , 1989, Seminars in oncology.

[15]  M. Pfeffer,et al.  Bioavailability and pharmacokinetics of etoposide (VP-16). , 1985, Seminars in oncology.

[16]  T. Ludden,et al.  Effect of food on blood hydralazine levels and response in hypertension , 1984, Clinical pharmacology and therapeutics.

[17]  T. Wagner,et al.  Pharmacokinetics and bioavailability of cyclophosphamide from oral formulations. , 1984, Arzneimittel-Forschung.

[18]  F. Juma,et al.  Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration. , 1979, British journal of clinical pharmacology.

[19]  S. Garattini,et al.  Variable oral absorption of hexamethylmelamine in man. , 1978, Cancer treatment reports.

[20]  W. H. Bond,et al.  Vincaleukoblastine. III. Clinical trial with the oral preparation. , 1961, Cancer chemotherapy reports.